Concepedia
Statistics
Publications
10
Citations
1.4K
H-Index
Active since
2005
Affiliations
AstraZeneca (United Kingdom)(Current)
University of Manchester
Cancer Research UK Manchester Institute
AstraZeneca (Singapore)
Emma Donald is an author at AstraZeneca (United Kingdom) specializing in medicine, cancer genetics, and molecular oncology.
Publications per year
2005–2021
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer
Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn et al. · Journal of Clinical Oncology · 2006 · 703 citations · Full text
Medicine, Molecular Genetics, Oncology +17
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Andrew Wardley, J. Michael Dixon, Anne Armstrong et al. · Breast Cancer Research and Treatment · 2010 · 199 citations · Full text
Medicine, Genetics, Oncology +16
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 153 citations · Full text
Medicine, Genetics, Oncology +17
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting
Kōichi Goto, Miyako Satouchi, Genichiro Ishii et al. · Annals of Oncology · 2012 · 103 citations · Full text
Medicine, Genetics, Oncology +12
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
Shethah Morgan, Jessica Whiteley, Emma Donald et al. · Clinical Medicine Insights Pathology · 2012 · 70 citations · Full text
1–5 of 10